A phase II study of prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer: comparison of 4'-epirubicin and adriamycin (Q72893439)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1994

Language	Label	Description	Also known as
English	A phase II study of prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer: comparison of 4'-epirubicin and adriamycin	scientific article published on 01 January 1994

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A phase II study of prophylactic intravesical chemotherapy with 4'-epirubicin in recurrent superficial bladder cancer: comparison of 4'-epirubicin and adriamycin (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

T Shuin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Y Kubota

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S Noguchi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

M Hosaka

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

T Miura

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

I Kondo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S Fukushima

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

E Ishizuka

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Furuhata

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

M Moriyama

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

35 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

S52-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Rationale for intensive intravesical chemotherapy for superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical doxorubicin for the prophylaxis of superficial bladder tumors. A multicenter study. Blinst Italian Cooperative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative prophylactic intravesical instillation of cytosine arabinoside and mitomycin C in superficial bladder tumor. A follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of 4'-doxorubicin analogs on heterotransplantation of human tumors in congenitally athymic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxic and therapeutic activity of 4'-epi-doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese Urological Cancer Research Group for Adriamycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative doxorubicin instillation in recurrent superficial bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7994787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00686920

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7994787%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72893439&oldid=2243097925"